At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
RFAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study for the Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
In Brief
A clinical study evaluating RFA for Papillary Thyroid Cancer and Papillary Thyroid Microcarcinoma. Completed, enrolled 5 participants across 1 site.
Detailed Summary
Investigators intend to evaluate the efficiency of Radiofrequency ablation (RFA) therapy to treat papillary thyroid carcinoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartJun 2020
Primary CompletionMay 2024
TodayJul 2026
First PostedOct 16, 2019
Enrollment StartJun 15, 2020
Primary CompletionMay 7, 2024
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 6.7 years ago
Interventions
RFAdevice
Radiofrequency ablation of selectively targeted thyroid nodule to treat papillary thyroid cancer.